BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2026 7:25:28 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-02-24 05:53 |
|
Peer-Review Started |
|
2026-02-24 05:54 |
|
First Decision by Editorial Office Director |
|
2026-03-06 09:18 |
|
Return for Revision |
|
2026-03-06 09:18 |
|
Revised |
|
2026-03-17 15:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-13 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-13 08:47 |
|
Articles in Press |
|
2026-05-13 08:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-04 13:10 |
|
Publish the Manuscript Online |
|
2026-08-13 07:25 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Observational Study |
| Article Title |
Role of fibroblast growth factor-23 in renal disease activity and bone density involvement in patients with lupus nephritis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nashwa M Azoz, Ammar A Ammar, Howaida A Nafady, Rabea A Gadelkareem, Essam M Abdel Aziz and Randa A Elzohne |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rabea A Gadelkareem, Assistant Professor, Department of Urology, Assiut Urology and Nephrology Hospital, Faculty of Medicine, Assiut University, Elgamaa Street, Assiut 71515, Egypt. rabeagad@aun.edu.eg |
| Key Words |
Bone mineral density; Chronic kidney disease; Fibroblast growth factor-23; Lupus nephritis; Renal disease activity; Systemic lupus erythematosus |
| Core Tip |
Fibroblast growth factor-23 (FGF-23) regulates mineral metabolism and may reflect both renal activity and skeletal involvement. The present study demonstrated that serum FGF-23 levels were significantly associated with renal disease activity and bone mineral metabolism (BMD) in patients with lupus nephritis. Elevated FGF-23 levels were correlated with impaired renal function and reduced BMD. Therefore, FGF-23 may be a valuable biomarker of renal disease activity and the risk of bone loss. Routine assessment of serum FGF-23 in patients with lupus nephritis may aid in risk stratification and disease monitoring. Additionally, those patients should undergo regular evaluation of BMD and mineral metabolism parameters. |
| Publish Date |
2026-08-13 07:25 |
| Citation |
Azoz NM, Ammar AA, Nafady HA, Gadelkareem RA, Abdel Aziz EM, Elzohne RA. Role of fibroblast growth factor-23 in renal disease activity and bone density involvement in patients with lupus nephritis. World J Nephrol 2026; 15(3): 120318
|
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i3/120318.htm |
| DOI |
https://doi.org/10.5527/wjn.v15.i3.120318 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
